Human Longevity makes three oncology appointments

February 4, 2016
Research and Development human longevity

Human Longevity, the genomics-based, technology company, has appointed ‘several key people’ for its oncology genomics program.Dr Kenneth Bloom will join …

AZ warns of patent losses as revenues fall

February 4, 2016
Medical Communications, Sales and Marketing AstraZeneca, Crestor, Zurampic

AstraZeneca announced full-year revenues down 7% to $24.7 billion, and Q4 sales down 5% to $6.4 billion, as the London-based …

Cancer – dealing with the greatest health challenge of our time

February 4, 2016
Manufacturing and Production, Research and Development Cancer, IFPMA, R&D, World Cancer Day, collaboration, partnership

Cancer is one of the greatest health challenges of our time, and a leading cause of death in every corner …

AstraZeneca’s Tagrisso gets EU lung cancer sign-off

February 4, 2016
Sales and Marketing AstraZeneca, European Commission, NSCLC, Tagrisso, non-small cell lung cancer, osimertinib

The European Commission (EC) has granted conditional marketing authorisation to AstraZeneca’s Tagrisso to treat locally advanced or metastatic non-small cell …

Revenues down at MSD

February 4, 2016
Sales and Marketing MSD, financial performance, profits, revenue, sales

MSD (Merck, Sharpe and Dohme) reported a mixed bag of financial figures today, as the company announced full-year 2015 revenues …

Emerging markets top global R&D spending league

February 4, 2016
Research and Development GDP, OECD, R&D spending, investment

Data from the Organisation for Economic Co-operation and Development (OECD) shows Korea and Israel are investing much more in research …

Revealed: analysts predict seven highest-earning pharma blockbusters

February 4, 2016
Sales and Marketing Gilead, OCA, Thomson Reuters, blockbusters, sales

Seven new drugs currently in development will enter the market this year – and earn sales of more than $1 …

Rodger Currie to lead advocacy at US pharma trade body

February 3, 2016
Medical Communications PhRMA, Pharmaceutical Research and Manufacturers of America

Rodger Currie has joined the Pharmaceutical Research and Manufacturers of America (PhRMA) association as executive vice president for advocacy.He will lead federal, …

London launches new cancer drug development hub

February 3, 2016
Research and Development

Research charities, hospitals, and London boroughs have combined to launch a new global hub for cancer research and treatment in …

GSK and Adaptimmune expand R&D collaboration

February 3, 2016
Research and Development Adaptimmune, GSK, T-cell therapy, immunotherapy, liposarcoma, rare cancer, sarcoma

Adaptimmune Therapeutics and GlaxoSmithKline have expanded the terms of their strategic collaboration agreement, to run clinical trials of Adaptimmune’s potential …

Daiichi Sankyo to expand access to clinical trial data

February 3, 2016
Research and Development Daiichi Sankyo, R&D, clinical trials, open access, open data, transparency

Daiichi Sankyo has announced today that it will share clinical trial data to qualified researchers through an online web request …

Sanofi plans R&D jobs cuts in France

February 3, 2016
Manufacturing and Production, Research and Development Sanofi, Teva, cuts, job losses, olivier brandicourt, redundancies

Sanofi chief executive Olivier Brandicourt is reported to be planning hundreds of job cuts across the firm’s base in France, …

Pfizer revenues down, but above expectations

February 3, 2016
Research and Development, Sales and Marketing Ian Read, Pfizer, financial results, income, profits, revenue, sales

Pfizer’s revenues took a hit from generic competition on former blockbusters, but the world’s new largest drugmaker still managed to …

Crescendo Biologics appoints Dr Barbara Fleck as head of intellectual property

February 2, 2016
Research and Development Crescendo Biologics

Drug discovery and developer Crescendo Biologics has appointed Dr Barbara Fleck as head of intellectual property. Barbara Fleck, a European and …

PCI and Partners host San Diego and San Francisco Serialization events

February 2, 2016
Manufacturing and Production

Professionals working in life science packaging and logistics can learn more about the fast-changing topic of Serialization at two free …

Porton Biopharma expands cancer drug manufacturing capacity

February 2, 2016
Manufacturing and Production, Research and Development Erwinase

UK Life Sciences Minister George Freeman yesterday opened a new multi-million pound pharmaceutical manufacturing facility at Wiltshire-based Porton Biopharma Limited …

Sun Pharma takes on Novartis in the US with generic Glivec

February 2, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Gleevec, Novartis, Sun Pharma

Mumbai-based drug manufacturer Sun Pharma has launched a generic version of Glivec, for the same indications for which the former …

Sanofi Pasteur launches Zika vaccine R&D

February 2, 2016
Manufacturing and Production, Research and Development Sanofi Pasteur, Vaccine, Zika virus

Sanofi Pasteur, the vaccines division of French pharma giant Sanofi, says it has launched a vaccine research and development project …

Europe approves BMS hep C drug for HIV and liver transplant patients

February 1, 2016
Research and Development, Sales and Marketing Bristol-Myers Squibb, daclatasvir, daklinza

The European Commission has approved the expanded use of Bristol Myers-Squibb’s hepatitis C drug Daklinza (daclatasvir), to include liver transplant …

AbbVie posts strong Q4 results

February 1, 2016
Sales and Marketing AbbVie, Humira, Viekira Pak

AbbVie managed to meet or beat analysts’ expectations in its Q4 financial results report, with extremely strong Humira sales contributing …

The Gateway to Local Adoption Series

Latest content